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The AKXL-5 recombinant inbred mouse strain is positive for the endogenous ecotropic murine leukemia
virus emv-14, the only emv present in its germ line. emv-14 is of particular interest because spleen cells
expressing emv-14 virus escape recognition by anti-AKR/Gross virus-specific cytotoxic T lymphocytes. We
report here the isolation and characterization of a replication-competent emv clone, pAK7, derived from an
AKXL-5 mouse. This clone is novel in that it encodes a variant ecotropic murine leukemia virus that, when
expressed in SC.Kb target cells, fails to be recognized efficiently by anti-AKR/Gross virus cytotoxic T
lymphocytes. The pAK7 clone can therefore be used to further probe mechanisms of escape from cell-mediated
immunity.
The AKR mouse strain has a high incidence of leukemia
that, although proximally caused by recombinant mink cell
focus-forming (MCF) murine leukemia virus (MuLV), is
dependent on the expression of endogenous ecotropic
MuLV (EMV) (22, 26). It has been shown that an H-2K'-
restricted cytotoxic T-lymphocyte (CTL) response can be
raised against tumor cells expressing EMV in C57BV/6 mice
(8, 11), which have a low incidence of leukemia. We have
designated these effector cells anti-AKR/Gross virus CTL.
The AKXL recombinant inbred strains (34), which were
generated from the AKR (H.2k, positive for emv-11, emv-13,
and emv-14) and the C57L (H-n, emv negative) progenitor
strains, were used to characterize the specificity of anti-
AKR/Gross virus CTL (10). Only spleen cells from AKXL
strains that were H-2b and emv-JJ positive could stimulate
an anti-AKR/Gross virus CTL response from tumor-primed
C57BL/6 responder cells. AKXL spleen cells that were
positive only for emv-14 or for emv-14 and the replication-
defective emv-13 could not stimulate a response. Corre-
spondingly, SC.Kb (H-2Ke) fibroblasts infected with emv-14
virus isolated from an AKXL-5 mouse (emv-14 positive
only) and used as targets in chromium-51 release assays
were not recognized by anti-AKR/Gross virus CTL (38).
These findings were curious, since emv-14 is replication
competent and expressed in a seemingly normal fashion. The
fact that H-2-compatible fibroblasts expressing virus from
AKXL-5 mice are not lysed by anti-AKR/Gross virus CTL
indicates that a mutation within the emv-14 provirus results
in a loss of CTL recognition. In addition, the defect must lie
at the level of target cell recognition rather than at some
earlier step, such as T helper cell function.
In order to further characterize this failure of CTL to
recognize AKXL-5 EMV, we cloned a replication-compe-
tent emv, pAK7, from AKXL-5 genomic DNA. Clone pAK7
is characterized and compared with pAKR623 (23), a provi-
rus that is derived from EMV-11. SC.Kb/623 fibroblast cells
* Corresponding author.
expressing AKR623 virus are lysed efficiently by anti-AKR/
Gross virus CTL (38). We show here that SC.Kb/7 cells
expressing virus from pAK7 are not lysed efficiently by
anti-AKR/Gross virus CTL. The pAK7 clone therefore
affords us the opportunity to study a mechanism by which a
retrovirus may escape destruction by antiviral CTL.
Isolation of clone pAK7 from AKXL-5 genomic DNA. DNA
(obtained from Ben Taylor, The Jackson Laboratory) from
the spleen cells of an AKXL-5 mouse (emv-14 positive,
emv-11 negative) was EcoRI restricted, and a fraction of 11
to 15 kb was used to construct a phage lambda library by
using the replacement vector EMBL-4. After identifying
positive clones with the emv-specific probe, which detects
only ecotropic DNA sequences and not xenotropic, ampho-
tropic, or MCF MuLV (2, 20), the clone XAK7 was grown by
standard procedures (33, 39) and subcloned into the EcoRI
site of pBR322 for use in further studies.
Analysis of pAK7 by restriction endonuclease mapping.
Figure 1 shows the restriction map of pAK7. Approximately
0.5 kb of 5'-flanking murine sequences and 3.5 kb of 3'-
flanking murine sequences surround the pAK7 provirus on
the EcoRI fragment cloned. All of the restriction sites
present in pAKR623 (sequence data are in references 14 and
37) that were tested for were found in equivalent locations in
pAK7. The pAK7 provirus has the hallmarks of an emv: (i)
it hybridizes with the emv-specific DNA probe; (ii) the
mapping data confirmed the expected SmaI and KjpnI sites
within the provirus; (iii) PstI sites were found only within the
long terminal repeats (LTRs), as expected (some xenotropic
viruses have a PstI site in thepol region which is not present
here and is never seen in emv proviruses [1], and there is a
PstI site in the env region of xenotropic and endogenous
polytropic viruses which is not present in clone pAK7 and is
never seen in emv viruses [1, 15, 16]); (iv) nonecotropic
endogenous proviruses all contain an EcoRI site in the env
region (1, 15, 35, 36), but there is none within the clone
pAK7 provirus or within emv proviruses; and finally, (v) the
expected emv-specific XbaI site within the pl5E coding
portion of env is seen in clone pAK7, this site being absent
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FIG. 1. Restriction map of clone pAK7. The fragment cloned and represented here is bounded by EcoRI sites. fl., flanking; arrows,
LTRs.
from xenotropic (16) and endogenous polytropic MuLV (3).
Thus, pAK7 represents an ecotropic provirus clone, not an
endogenous xenotropic or polytropic MuLV.
Identification of an RFLP in pAK7 relative to pAKR623.
After close inspection of restriction digests of pAK7 and
comparison with those of the emv-11-like clone pAKR623
(kindly provided by S. K. Chattopadhyay [23] through B. A.
Taylor), a restriction fragment length polymorphism (RFLP)
was found in the LTR region (Fig. 2). Both the SmaI and the
KpnI fragments corresponding to the 3' env/LTR region of
pAK7 are shortened by approximately 100 bases compared
with the fragments from pAKR623. By doubly digesting each
of the two clones with KpnI and PstI, the location of the
RFLP was further defined as being within the U3R region of
the LTR. It is noteworthy that the direct repeat in the
enhancer region of the U3 portion of the LTR is approxi-
mately 100 bp long and is duplicated in pAKR623. Similar
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FIG. 2. Ethidium bromide-stained gel, showing the RFLP of
clone pAK7 relative to pAKR623. (A) Lanes 1 and 3, pAKR623;
lanes 2 and 4, pAK7; lanes 1 and 2, digestions with KpnI; lanes 3 and
4, digestions with SmaI. (B) Lane 2, pAKR623 doubly digested with
KpnI and PstI; lane 3, pAK7 doubly digested with IpnI and PstI.
Lanes A5 and B1 contain size standards (in kilobases). The arrows
point to the SmaI (S) and KpnI (K) RFLPs in panel A and to the
KpnI-PstI (K/P) RFLP in panel B. Other differences in banding
between pAK7 and pAKR623 are due to differences in the flanking
sequences (see Fig. 1).
polymorphisms in the LTR have been shown by others (29,
30).
Expression of AK7 virUs in fibroblast cells. In order to
characterize the virus derived from the pAK7 clone, SC.Kb
cells (38) were used to express AK7 virus. SC.Kb cells are
emv negative and express the appropriate major histocom-
patibility complex (MHC) restricting element for use as a
target cell line for H-2K'-restricted anti-AKR/Gross virus
CTL. The TCRIP cell line (kindly provided by Richard
Mulligan [6]) was used to pseudotype the virus to facilitate
infection into SC.Kb cells.
SC.Kb cells were infected with AK7 virus or with AKR623
virus for comparison, resulting in the SC.Kb/7 and SC.Kb/
623 cell lines, respectively. Cell surface viral antigen expres-
sion was analyzed by indirect immunofluorescence and
fluorescence-activated cell sorting (FACS) analyses. The
monoclonal antibody 24-8 (mouse immunoglobulin G2a
[IgG2a]) binds to the emv gp70 envelope antigen (28). The
monoclonal antibody 548 (mouse IgG2b) binds pl29a9 anti-
gens (4). Figure 3 shows the results after a period of weeks,
when virus expression had reached steady-state levels. It
can be seen that the levels of expression of gp7O detected by
the anti-gp70 monoclonal antibody 24-8 (fluorescence inten-
sity measured with a linear amplifier) are similar for both
SC.Kb/7 and SC.Kb/623 cells, while there is no expression of
EMV-specific gp7O on uninfected SC.Kb cells. The levels of
anti-pl5Ec (determined with antibody 19-F8 [25]; data not
shown) and anti-pl2lag antibody binding are also similar for
SC.Kb/7 and SC.Kb/623 cells. Other monoclonal antibodies
against various gag- and env-encoded epitopes gave similar
results as well (data not shown). In some FACS analyses,
the levels of viral antigen expression were slightly greater on
SC.Kb/7 cells than on SC.Kb/623 cells. The two cell lines
described here were chosen for further CTL analyses (be-
low) because of their consistent expression of nearly equal
levels of cell surface viral antigens.
SC.Kb/7 cell supernatant fractions were positive when
assayed for reverse transcriptase activity (31), with levels
similar to those observed for SC.Kb/623 supernatant frac-
tions (data not shown). In summary, steady-state levels of
expression of AK7 gag-, pol-, and env-encoded antigens are
essentially equivalent to those of AKR623 antigen expres-
sion. RNA blot analysis with the emv-specific probe against
RNA isolated from SC.Kb/7 cells confirmed that pAK7
encodes an ecotropic MuLV (data not shown).
SC.Kb/7 target cells are lysed poorly by anti-AKR/Gross
virus CTL. The SC.Kb/7 cells were then assayed at the target
level against anti-AKR/Gross virus CTL. These H-2K"-
restricted C57BL/6 CTL were raised by in vivo priming and
secondary in vitro stimulation with MHC-compatible AKR/
Gross virus-induced tumor cells as described previously (11,
27). Each chromium release experiment was performed in
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FIG. 3. FACS analysis of the expression of EMV on SC.Kb cells
infected with AK7 or AKR623 virus. The pAK7 or pAKR623
plasmid was used along with plasmid pSVhisr (obtained from R.
Mulligan), carrying the dominant selectable Hisr marker to transfect
'lCRIP cells by the calcium phosphate DNA coprecipitation method
(7) to generate the AlCRIP7 and 'ICRIP623 cell lines, respectively.
Cell-free supernatant fractions were used to generate the SC.Kb/7
and SC.Kb/623 lines, respectively, from Polybrene-treated (20 ,ug/
ml) SC.Kb cells. The expression of EMV on these cells was
analyzed by cytofluorography and indirect immunofluorescence
with monoclonal antibodies against gp7O (24-8, shaded bars) and p12
(548, hatched bars) (see text). The staining procedure used has been
described before (38). Background fluorescence values were deter-
mined with the following irrelevant monoclonal antibodies used as
isotype controls: OKT8 (CRL 8014, anti-CD8 mouse IgG2a) for 24-8
and OKM1 (CRL 8026, mouse IgG2b, against the integrin C3bi
receptor on monocytes) for 548. The secondary antibody used was
fluorescein isothiocyanate-labeled goat anti-mouse polyvalent
F(ab')2 (Cappel). Nonspecific fluorescence was subtracted from the
fluorescence values, measured with a linear amplifier. Flow cytom-
etry analysis was performed on an Ortho 50H cytofluorograph.
duplicate and with two independent sets of stimulated effec-
tors. This experiment was performed three times with simi-
lar results. SC.Kb/7 targets are lysed by these CTL at lower
levels than SC.Kb/623 targets (Fig. 4). Thus, clone pAK7
encodes an EMV that fails to be recognized efficiently by
anti-AKR/Gross virus CTL, similar to the low response by
these CTL against spleen cell targ,ets expressing emv-14 (10).
The poor recognition of SC.K /7 targets occurs despite
similar steady-state levels of gag-, pgol-, and env-encoded
viral antigens for SC.Kb/7 and SC. /623 (see above).
Clone pAK7 encodes replication-competent virions. Be-
cause the previous assays were insufficient to determine
whether pAK7 encoded infectious, replication-competent
virus, the standard XC plaque assay (21, 32) was performed.
No virus could be detected for SC.Kb/7 cells by this method,
even when repeated four times over a period of months,
whereas titers were typically in the 105 to 106 PFU/ml range
for SC.Kb/623 cells. The lack of XC positivity was curious
because earlier experiments with extracts from tail tissue
from AKXL-5 mice, which carry only emv-14, showed that
this strain was viremic by the XC plaque assay (34, 38).
Some possible explanations for this discrepancy are: (i)
pAK7 encodes a replication-defective virus; (ii) pAK7 en-
codes a replication-competent virus that is not detectable on
the basis of overt plaques by the XC plaque assay; and (iii)
XC-positive virus detected in AKXL-5 mice is an XC-
positive derivative of EMV-14, and virus expressed directly
from the emv-14 locus is XC negative.
To distinguish among these possibilities, a virus transfer
experiment was done. Cell-free virus (unaided by helper
virus) from SC.Kb/7 or SC.Kb/623 cells was used to infect
fresh virus-negative SC.Kb cells. When the resultant SC.Kb/
7P2 (secondary passage) cells were assayed for virus expres-
sion by FACS analysis over time, the level of expression of
gp70 and p12 antigens was lower at first than in SC.Kb/623P2
cells but approached high steady-state levels by 4 to 6 weeks
after infection (Fig. 5). The initial rate of virus expression for
the secondary-passaged AK7 was also similar to that for the
primary-passaged AK7 (data not shown). In contrast, the
expression of virus on SC.Kb/623P2 cells was maximal by 1
week postinfection, the earliest time point measured. These
experiments indicate that pAK7 does encode infectious
virus, although the initial rate of appearance of viral antigens
after infection is more rapid for pAKR623-encoded virus
(selected for its ability to spread rapidly) than for pAK7-
encoded virus.
When SC.Kb/7 cells (primary passage) were cocultured in
equal numbers with XC cells and the plates were stained 24
and 48 h later, giant multinucleated cells were observed in
numbers similar to those seen for SC.Kb/7P2 and SC.Kb/623
in parallel assays. SC.Kb cells failed to induce giant multi-
nucleated cells, as expected. This experiment was per-
formed twice with the same results. Thus, although SC.Kb/7
cells appear to be XC plaque assay "negative," at least as
defined by the presence of obvious plaques in the standard
assay, they are XC positive in a cocultivation assay, indi-
cating the presence of functional virus.
Interestingly, when SC.Kb/7p cells were assayed by the
standard XC plaque assay, they scored positive in two of
two experiments, each in triplicate, indicating that the AK7
virus had acquired overt XC positivity after passage. None-
theless, these SC.KbI/72 cells still failed to be lysed effi-
ciently by bulk antiviral CTL despite their XC positivity. At
an effector-to-target cell ratio of 100:1, 95% of SC.Kb/623
targets were lysed, whereas SC.Kb/7p2 targets and unin-
fected SC.Kb targets were lysed at similar low levels (22 and
16%, respectively). Thus, the mutation responsible for ap-
parent XC negativity is separate from the mutation(s) re-
sponsible for low levels of lysis by CTL. The secondary
virus passage data also confirm the original finding (38) that
the integration of virus into new sites within the murine
genome, as shown here for SC.Kb/7P2, fails to alter the CTL
phenotype, indicating that proviral flanking sequences are
not responsible for the low levels of lysis by CTL.
It is unlikely that the slower appearance of viral antigens
following de novo infection is responsible for the poor
recognition by CTL, since CTL assays were done when viral
antigens were at steady-state levels and those levels were
roughly equivalent between SC.Kb/7 and SC.Kb/623 cells.
Furthermore, the two target cell lines should not differ in
antigen processing or presentation, since the same SC.Kb
line was used for each infection. Although we think it
unlikely that the rate of virus spread for AK7 contributes to
poor recognition by CTL, future studies with a chimera of
pAK7 containing the pAKR623 LTRs would be useful for
resolving this possibility.
Clone pAK7 represents an emv-14 reintegration locus. Be-
cause clone pAK7 encodes replication-competent EMV and
because the source of DNA used for constructing the library
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FIG. 4. Failure of anti-AKR/Gross virus CTL to lyse SC.Kb/7 target cells. CTL were raised as described in the text and previously (38).
Data for CTL stimulated with irradiated EdG2 (derived from a C57BL/6 tumor induced with AKR/Gross virus passage A [11]) effectors are
shown here. Control fibroblast cells (unbroken lines) were SC-1 (EMV negative, derived from a wild mouse embryo [12]), SC.Kb (H-2b [38]),
and SC.Kb/623 (SC.Kb cells infected with AKR623 EMV). Control tumor cells (dashed lines) were SL1 (AKR.H-2b-derived spontaneous
tumor cell); clone 18-5, a variant line derived from SL1 that is only poorly recognized by anti-AKR/Gross virus CTL (9); and YAC-1, an H-2z
tumor cell line that is used here as a highly natural killer cell-sensitive target cell to control for natural killer cell killing.
from which pAK7 was isolated carried only emv-14, clone
pAK7 must ultimately be derived from the emv-14 locus.
Southern blot analysis with both emv-specific and pAK7
flanking cellular DNA probes indicated that the provirus
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FIG. 5. Time course of cell surface virus expression after sec-
ondary passage of virus. FACS analysis (as in Fig. 3) showing the
rates of appearance of virus expression from a secondary-infection
experiment in which SC.Kb cells were infected with the supernatant
fractions from SC.Kb/7 or SC.Kb/623 (Fig. 3), resulting in SC.Kb/7p2
and SC.Kb/623P2, respectively. Solid symbols, 24-8 (anti-gp70);
open symbols, 548 (anti-p12); squares, SC.Kb/7p2; triangles, SC.K I
623P2.
cloned represents a reintegration site rather than the emv-14
locus per se (data not shown). The genomic DNA used to
construct the library from which XAK7 was cloned was
isolated from a 1.5-year-old mouse (these mice are now
extinct) and therefore probably contains new proviral inte-
grations as a result of reinfection by EMV expressed from
the emv-14 locus. It is therefore likely that pAK7 represents
a genomic clone of one such reintegrated, emv-14-derived
provirus.
Regarding the slower rate of appearance of virus expres-
sion after infection with AK7 than after infection with
AKR623, it should be noted that AKR623 was isolated after
multiple passages that would select viruses that replicate
most efficiently (23). One reason for the differences in the
rates of appearance of virus expression demonstrated here
between AK7 and AKR623 may be in the U3 enhancer
region of the LTR. AKR623 has a direct repeat (a duplication
of about 100 bp), and it is well known that, in general,
multiple enhancers are more effective at increasing tran-
scription rates than single copies. It is interesting, then, that
pAK7 has a deletion (or rather a lack of duplication) of
approximately 100 bp in this region relative to pAKR623,
and this RFLP may reflect a single 100-bp enhancer-like
direct repeat rather than the duplication seen in pAKR623.
Examples of emv proviruses with a single direct repeat
include emv-1 (18) and emv-3 (19). There are other examples
of LTR polymorphisms between emv's as well (29, 30).
It is also possible that the single direct repeat in the U3
region of pAK7 is partly responsible for the inability of
pAK7-encoded virus to score positive in the XC plaque
assay, if the kinetics of the AK7 replication cycle are too
slow to allow sufficient virus spread within the time frame of
the assay. Yet the overtly XC-positive SC.KbI7P2 line exhib-
ited a slow initial appearance of viral antigens, similar to that
J. VIROL.
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with SC.Kb/7. An alternative explanation is that AK7 has an
altered determinant that is involved in syncytium formation,
as may be the case for XC-negative infectious MuLV found
by others. For example, neither MCF-infected mink cell
cultures nor MCF-infected mouse cell cultures develop
syncytia when cocultivated with XC cells (13). There are
also N-tropic MuLV variants that are infectious but XC
plaque assay negative (5, 17, 24). Whatever mutation(s) is
responsible for the XC negativity (as defined by the absence
of obvious plaques), the XC phenotype becomes positive
upon secondary passage of the AK7 virus and thus does not
correlate with the dysfunctional CTL phenotype.
In summary, we have cloned and characterized an infec-
tious EMV variant, AK7, and cells expressing this immuno-
logic variant fail to be recognized efficiently by anti-AKR/
Gross virus CTL. SC.Kb/7 cells can now be used to further
define the viral epitope(s) that is missing or altered in AK7
relative to AKR623. In addition, AK7 virus-positive cells
can be used to determine whether AK7-specific CITL can be
induced, and the mechanism by which this virus evades CTL
recognition can be studied further. Such evasion of cellular
immunity, a primary defense against retroviral infection, is
one way in which virus-induced tumors may escape immune
surveillance and become established.
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